Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07558265 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department

Study acronym: WINDSURFER
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 4 more changesShow less
    • Trial sites expanded: 2 → 6 locations
    • Start date changed from estimate of Jul 2026 to Aug 18, 2026
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints: details revised at 3 of 3 entries
  2. Notable Primary endpoint(s) modified
    • Trial sites reduced: 19 → 2 locations
    v3
  3. Notable Primary endpoint revised
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints revised (3)
    • Study description shortened, about 145 words
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
1,119 trials monitored
See 34 trials at risk
The purpose of this clinical trial is to determine the best initial non-invasive respiratory support (NIRS) strategy for adults who present to the emergency department with acute hypoxemic respiratory failure, a condition in which blood oxygen levels are dangerously low and require urgent treatment. This study compares two commonly used non-invasive respiratory support strategies to evaluate their effectiveness and safety, based on important patient outcomes during hospitalization, including survival, the need for invasive mechanical ventilation, and the duration of respiratory support. Participants will be randomly assigned (with an equal chance) to receive one of the following treatments: * Non-Invasive Positive Pressure Ventilation (NIPPV): Oxygen delivered under pressure through a face mask. * High-Flow Nasal Oxygen (HFNO): Oxygen delivered at high-flow through a specially designed nasal cannula placed in the nostrils. Researchers will compare the two treatment strategies using a hierarchical assessment of major pulmonary outcomes, including: * Hospital survival * Days on mechanical ventilation * Duration of non-invasive respiratory support As part of the study, researchers will collect: * Blood and urine samples * Physiologic measurements (such as chest movement measured through sensors placed on the skin) * Information from participants' medical records
Trial Details
NCT Number NCT07558265
Lead Sponsor Ohio State University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), University of Michigan, Medical University of South Carolina, University of Arizona, Baystate Medical Center
Conditions
(from sponsor)
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
Related terms Pulmonary Disease, Chronic Obstructive, Respiratory Distress Syndrome, Respiratory Insufficiency
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov